AZD8797
AZD8797 (KAND567) is an orally available, selective and potent human CX3CR1-converting antagonist with inhibitory effects on CX3CR1 and CXCR2, and potentially protects against SARS-CoV-2-induced neuronal damage, preventing worsening of nociceptive sensitization and microglial activation in a migraine model of rats following seizures.
Product Specifications
CAS Number
911715-90-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
403.56
Molecular Formula
C19H25N5OS2
Notes
Research use only, not for human use.
Receptor
CXCR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
